Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates

Publisher： Karger

E-ISSN： 1421-9875|31|3-4|368-373

ISSN： 0257-2753

Source： Digestive Diseases, Vol.31, Iss.3-4, 2013-11, pp. : 368-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Colorectal Cancer in Inflammatory Bowel Disease: Value of Screening and 5-Aminosalicylates

By  

Digestion, Vol. 73, Iss. 1, 2009-01 ,pp. : 11-19

Karger

Access to resources Recommend Favorite

Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

By  

Digestive Diseases, Vol. 27, Iss. 1, 2010-03 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

The surgical treatment of inflammatory bowel disease-associated dysplasia

By Connelly Tara M   Koltun Walter A  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 4, 2013-05 ,pp. : 307-322

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Bowel Disease Characteristics and Treatment in Hispanics and Caucasians

By Hou Jason   El-Serag Hashem   Sellin Joseph   Thirumurthi Selvi  

Digestive Diseases and Sciences, Vol. 56, Iss. 5, 2011-05 ,pp. : 1476-1481

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of anaemia in inflammatory bowel disease with iron sucrose

By Bodemar G.   Kechagias S.   Almer S.   Danielson B. G.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 5, 2004-05 ,pp. : 454-458

Informa Healthcare

Access to resources Recommend Favorite